Yoga therapy on elderly patients with fear of fall: an open-label randomised controlled trial (YOFEAR trial).

Aging GERIATRIC MEDICINE Health & safety Quality in health care REHABILITATION MEDICINE

Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
27 Dec 2023
Historique:
medline: 28 12 2023
pubmed: 28 12 2023
entrez: 27 12 2023
Statut: epublish

Résumé

Fear of fall is experienced by the elderly irrespective of the presence or absence of history of fall. Falls contribute to injuries that culminate in hospitalisation that incur unwarranted medical expenses. Yoga is unique to Indian cultural practices, with a potential to enhance proprioception. It increases self-body awareness, ultimately improving the balancing capacity of older adults. Thus, the objective of this study is to compare the effect of yoga therapy in the study and control groups at 12 weeks from the baseline. This study is designed as an open-label, randomised controlled trial (1:1) with a sample size of 62 elderly patients more than or equal to 60 years of age. Participation of either sex, male or female with a fear of fall will be considered. Two randomised groups of 31 participants each will receive standard therapy for their primary diseases as per the local, national or international guidelines. However, participants in the intervention arm will receive additional structured yoga therapy sessions. The primary objective of this study is to assess and compare the change in fear of fall score of participants in each group using Falls Efficacy Scale (FES) and Berg Balance Scale (BBS) at 12 weeks versus baseline. The secondary endpoint will assess the change in the quality of life of participants at 3 months compared with the baseline.Data will be gathered, entered into Microsoft Excel and further analysed by R software (V.4.3.0). Changes in FES-Intervention and BBS of two groups will be compared either by Student's t-test for parametric data or Mann-Whitney U test for non-parametric data. Statistical significance will be considered if p<0.05 at 95% confidence level. Ethical approval for this study protocol (version 1.0, 22 April 2022) was obtained from the institute ethics committee (AIIMS/IEC/22/195). CTRI/2022/06/043287.

Identifiants

pubmed: 38151281
pii: bmjopen-2022-070540
doi: 10.1136/bmjopen-2022-070540
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e070540

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Kritartha Kashyap (K)

Geriatric Medicine, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.

Minakshi Dhar (M)

Geriatric Medicine, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India minakshi.dhar@rediffmail.com.
Internal Medicine, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.

Khushboo Bisht (K)

Clinical Pharmacology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.

Yogesh Bahurupi (Y)

Community & Family Medicine, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.

Monika Pathania (M)

Geriatric Medicine, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.

Classifications MeSH